1-3 of 3
Claus R. Bartram, PhD
Close
Sort by
Journal Articles

Reduced Intensity Delayed Intensification in Standard-Risk Patients Defined By Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia: Results of an International Randomized Trial in 1164 Patients (Trial AIEOP-BFM ALL 2000)

Martin Schrappe, MD, Martin Zimmermann, PhD, Anja Möricke, MD, Georg Mann, MD, Maria Grazia Valsecchi, PhD, Claus R. Bartram, PhD, Andrea Biondi, MD, Renate Panzer-Grümayer, MD, Rita Beier, MD, Gunnar Cario, Franco Locatelli, MD, Giuseppe Basso, Felix Niggli, MD, Maurizio Aricò, MD, Valentino Conter
Journal: Blood
Blood (2016) 128 (22): 4.
https://doi.org/10.1182/blood.V128.22.4.4
Published: 2016
Journal Articles

Evaluation of Minimal Residual Disease As a Surrogate Endpoint for Event Free Survival in Childhood B-Lineage Acute Lymphoblastic Leukemia

Maria Grazia Valsecchi, PhD, Meenakshi Devidas, PhD, Ausiliatrice Lucenti, PhD, Martin Schrappe, MD, Giovanni Cazzaniga, PhD, Anja Moricke, MD, Claus R. Bartram, PhD, Georg Mann, MD, William L. Carroll, MD, Eric Larsen, MD, Naomi Winick, MD, Giuseppe Basso, MD, Valentino Conter, Martin Zimmermann, PhD, Stefan Sushu, Andrea Biondi, MD, Stephen Hunger, MD, Stefania Galimberti, PhD
Journal: Blood
Blood (2016) 128 (22): 759.
https://doi.org/10.1182/blood.V128.22.759.759
Published: 2016
Journal Articles

Impact of Minimal Residual Disease (MRD) on Prognosis in Children with Acute Lymphoblastic Leukemia (ALL) According to WBC Count, Age and TEL/AML1 Status at Diagnosis. Results of the AIEOP-BFM ALL 2000 Study.

Valentino Conter, MD, André Schrauder, MD, Helmut Gadner, MD, Maria Grazia Valsecchi, PhD, Martin Zimmermann, PhD, Michael Dvorzak, MD, Andrea Biondi, MD, Claus R. Bartram, PhD, Giuseppe Basso, MD, Martin Stanulla, MD, Maurizio Aricò, MD, Karl Welte, MD, Giuseppe Masera, MD, Martin Schrappe, MD
Journal: Blood
Blood (2007) 110 (11): 544.
https://doi.org/10.1182/blood.V110.11.544.544
Published: 2007